FCA
EBS icon

FinTrust Capital Advisors’s Emergent Biosolutions EBS Stock Holding History

FinTrust Capital Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,000
Closed -$13K – 1150
2020
Q2 		$13K Buy
+2,000
New +$149K 0.01% 685

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

FinTrust Capital Advisors's EBS Position: Q3 2020 in Review

FinTrust Capital Advisors sold out of Emergent Biosolutions (EBS) in Q3 2020, closing a stake of 3,300 shares — an estimated $261K sold.

FinTrust Capital Advisors first reported a position in EBS in Q4 2018 and held it in 3 quarters. The position peaked at $562K in Q1 2020. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

  • FinTrust Capital Advisors reported no remaining Emergent Biosolutions position as of Q3 2020 after selling out during the quarter.
  • FinTrust Capital Advisors sold 3,300 Emergent Biosolutions shares in Q3 2020, an estimated $261K.
  • FinTrust Capital Advisors first reported a position in Emergent Biosolutions in Q4 2018 and held it in 3 quarters.
  • FinTrust Capital Advisors's Emergent Biosolutions position peaked at $562K in Q1 2020.
  • 358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on FinTrust Capital Advisors's 13F filing for Q3 2020, filed 10 Nov 2020.